ENTX
Entera Bio (ENTX)
$30
About Entera Bio (ENTX)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Details
Daily high
$1.35
Daily low
$1.25
Price at open
$1.35
52 Week High
$3.22
52 Week Low
$0.91
Market cap
60.6M
Dividend yield
0.00%
Volume
158,557
Avg. volume
220,464
P/E ratio
-5.22
Entera Bio News
Details
Daily high
$1.35
Daily low
$1.25
Price at open
$1.35
52 Week High
$3.22
52 Week Low
$0.91
Market cap
60.6M
Dividend yield
0.00%
Volume
158,557
Avg. volume
220,464
P/E ratio
-5.22